36E79727R0001_1.docx
DOCX document 25 KB Posted
- Attached to
- Filgrastim Biosimilar (VA-27-00012533)
- Solicitation number
- 36E79727R0001
About this file
This is a Request for Information (RFI) issued by the Department of Veterans Affairs National Acquisition Center for Filgrastim Biosimilar products. The RFI seeks information from potential vendors regarding their capability to supply filgrastim biosimilar medications to support VA healthcare facilities nationwide. The document outlines the VA's interest in understanding market availability, product specifications, manufacturing capabilities, regulatory status, and pricing models for filgrastim biosimilar products that meet FDA approval requirements and are bioequivalent to the reference biologic product.
Respondents are requested to provide detailed information on product availability, shelf life, storage requirements, quality assurance protocols, supply chain capacity, and proposed pricing structures. The RFI emphasizes the importance of meeting current Good Manufacturing Practice (cGMP) standards and maintaining compliance with all applicable federal regulations. This pre-solicitation activity allows the VA to gather market intelligence and assess vendor capabilities prior to issuing a formal competitive solicitation. Interested vendors should respond according to the instructions outlined in the RFI document, which will inform the VA's procurement strategy and facilitate future contract award decisions for filgrastim biosimilar supply contracts.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Presolicitation Notice Presolicitation Notice
| SUBJECT* |
| Filgrastim Biosimilar (VA-27-00012533) |
GENERAL INFORMATION
| CONTRACTING OFFICE’S ZIP CODE* |
| 60141 |
| SOLICITATION NUMBER* |
| 36E79727R0001 |
| RESPONSE DATE/TIME/ZONE |
| 12-15-2026 2:30 PM CENTRAL TIME, CHICAGO, USA |
| ARCHIVE |
| 99 DAYS AFTER THE RESPONSE DATE |
SET-ASIDE
| PRODUCT SERVICE CODE* |
| 6505 |
| NAICS CODE* |
| 325412 |
PLACE OF PERFORMANCE
POSTAL CODE
COUNTRY
CONTACT INFORMATION
| CONTRACTING OFFICE ADDRESS |
| Department of Veterans Affairs |
OPAL/National Acquisition Center Building 37 1st Avenue, One Block North of Cermak
POINT OF CONTACT*
Contract Specialist Dov Vysnia Dov.Vysnia@va.gov 708-786-5145
ADDITIONAL INFORMATION
AGENCY’S URL
URL DESCRIPTION
| AGENCY CONTACT’S EMAIL ADDRESS |
| Dov.Vysnia@va.gov |
| EMAIL DESCRIPTION |
| Agency POC Email |
DESCRIPTION
PRE-SOLICITATION NOTICE: The VA Enterprise Procurement Office intends to issue Request for Proposal (RFP) 36E79727R0001 for an unrestricted procurement for Filgrastim or Biosimilar Syringes, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH2)), Department of Defense (DoD) (inclusive of Tricare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).
VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA’s and DOD’s respective Pharmaceutical Prime Vendor Programs. One or more of the items under this acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements.
Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere on top of the successful offeror/contractor’s label. All units identified in the Schedule of Supplies (Line Items 1 and 2, 300 mcg and 480 mcg syringes) shall be non-safety syringes. Each syringe shall be indicated and labeled for patient or caregiver use. Offerors must make all commercial packages available (i.e.1 Syringe,1 Box of (10) Syringes).
Solicitation # 36E79727R0001 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about December 01, 2026, with a tentative closing date of December 15, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Dov Vysnia. Questions can be e-mailed to Dov.Vysnia@va.gov.
The estimated annual requirements are as follows:
| Item |
| Description |
| Package Size (Syringe) |
| Total Estimated Annual Usage (Syringe) |
| 1 |
| FILGRASTIM 300MCG SYRINGE |
(Non-Safety)* OR Biosimilar
| 1 |
| 22,665 |
| 2 |
| FILGRASTIM 480MCG SYRINGE |
(Non-Safety)* OR Biosimilar
| 1 |
| 29,170 |
*SYRINGE MUST BE LABELED FOR USE BY A PATIENT OR CAREGIVER
| *=Required Field |
| Presolicitation Notice |
Presolicitation Notice
File details come from the government source that posted it. Updated .